Effectiveness of Tulsi and Krishna Tulsi in Prameha

Randomised comparative clinical trial to evaluate the efficacy of Tulsi and Krishna Tulsi(Ocimum Sanctum Linn.) in Prameha w..s.r. to Pre-diabetes

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/033927

Enrollment

Registered

2021-06-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R730- Abnormal glucose

Interventions

Intervention1: Tulsi Capsule: Group A-15 patients of prameha will be selected and 3 tulsi capsules per day will be given orally before meal twice a day for 1 month Control Intervention1: Ksishna Tulsi

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients in the age group of 20-60 years. 2. Patients with fasting blood sugar in the range of 100-125mg/dl,post prandial blood sugar in range of 140-199mg/dl

Exclusion criteria

Exclusion criteria: 1.Patients having type 1 DM. 2.Patients having any serious illness like coronary artery disease, malignancy, kidney disease etc. 3.Patient whose FBS >125mg/dl or PPBS >200mg/dl 4.Pregnant and Lactating mother.

Design outcomes

Primary

Measure	Time frame
Changes in blood glucose level.Timepoint: 4 weeks	—

Secondary

Measure	Time frame
Changes in triglyceride,HDL,LDL,Cholestrol level and BMI.Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Preeti

National Institute Of Ayurveda

armurthy_2005@yahoo.com9314513659

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026